-
FBT Dashboard
- Holdings
First Trust NYSE Arca Biotechnology Index Fund
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
BGNE BeiGene, Ltd. | 55.24 mm | 246.03 k shares | 4.58 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 55.01 mm | 807.54 k shares | 4.56 | Common equity | Long | USA |
CORT Corcept Therapeutics Incorporated | 55.00 mm | 1.19 mm shares | 4.56 | Common equity | Long | USA |
BNTX BioNTech SE | 52.34 mm | 440.70 k shares | 4.34 | Common equity | Long | Germany |
CPRX Catalyst Pharmaceuticals, Inc. | 44.89 mm | 2.26 mm shares | 3.72 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 44.87 mm | 535.13 k shares | 3.72 | Common equity | Long | USA |
WAT Waters Corporation | 44.56 mm | 123.80 k shares | 3.69 | Common equity | Long | USA |
ALKS Alkermes plc | 44.46 mm | 1.59 mm shares | 3.69 | Common equity | Long | Ireland |
RGEN Repligen Corporation | 44.25 mm | 297.31 k shares | 3.67 | Common equity | Long | USA |
ARGX argenx SE | 43.51 mm | 80.27 k shares | 3.61 | Common equity | Long | Netherlands |
EXEL Exelixis, Inc. | 43.37 mm | 1.67 mm shares | 3.60 | Common equity | Long | USA |
NTRA Natera, Inc. | 42.59 mm | 335.46 k shares | 3.53 | Common equity | Long | USA |
ILMN Illumina, Inc. | 42.06 mm | 322.49 k shares | 3.49 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 41.74 mm | 116.49 k shares | 3.46 | Common equity | Long | USA |
MTD Mettler-Toledo International Inc. | 41.31 mm | 27.54 k shares | 3.43 | Common equity | Long | USA |
HALO Halozyme Therapeutics, Inc. | 40.30 mm | 703.98 k shares | 3.34 | Common equity | Long | USA |
BRKR Bruker Corporation | 39.93 mm | 578.19 k shares | 3.31 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 39.53 mm | 143.71 k shares | 3.28 | Common equity | Long | USA |
INCY Incyte Corporation | 38.87 mm | 588.09 k shares | 3.22 | Common equity | Long | USA |
AMGN Amgen Inc. | 36.46 mm | 113.16 k shares | 3.02 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 35.78 mm | 34.03 k shares | 2.97 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 35.63 mm | 76.60 k shares | 2.95 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies, Inc. | 35.06 mm | 479.17 k shares | 2.91 | Common equity | Long | USA |
GMAB Genmab A/S | 33.74 mm | 1.38 mm shares | 2.80 | Common equity | Long | Denmark |
ACAD ACADIA Pharmaceuticals Inc. | 32.40 mm | 2.11 mm shares | 2.69 | Common equity | Long | USA |
BIIB Biogen Inc. | 31.54 mm | 162.73 k shares | 2.62 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 30.95 mm | 440.34 k shares | 2.57 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 30.74 mm | 246.12 k shares | 2.55 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 29.26 mm | 253.94 k shares | 2.43 | Common equity | Long | USA |
MRNA Moderna, Inc. | 20.60 mm | 308.23 k shares | 1.71 | Common equity | Long | USA |
Dreyfus Government Cash Management | 939.65 k | 939.65 k shares | 0.08 | Short-term investment vehicle | Long | USA |
BOFA SECURITIES INC | 3.47 k | 3.47 k principal | 0.00 | Repurchase agreement | Long | USA |